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There is a consensus in the psychotherapy research
field to consider the therapeutic alliance, broadly
defined as the mutual collaboration between the
therapist and the patient,as a robust and consistent
predictor of therapy outcome.There is little agree-
ment, however, on the best way to operationalise
and measure it. Several instruments are available,
each of them displaying some unique features so
that investigators have problems to choose among
them on the basis of considerations other than 
ease of administration, continuity with previous
research or availability.
One of the early self-report measures and
widely used instruments was the Helping Alliance
questionnaire (HAq-I) (Alexander and Luborsky,
1986). In recent years, we have become aware 
that it was limited by the presence of items that
were explicitly assessing early symptomatic im-
provement and by the fact that all the items were
worded positively.A revised version (HAq-II) was
developed (Luborsky et al., 1996), guided by two
main goals: (1) to reduce the inclination of the scale
toward measuring early symptomatic improvement
and thus confusing these two dimensions, and (2)
to better incorporate the various aspects of the
alliance related to the collaborative effort of pa-
tient and therapist. The new instrument includes 
5 from the 11 items of the HAq-I and 14 new 
items – 5 of them worded negatively.
The aim of the study is twofold: to validate the
French version of the new HAq-II and to investi-
gate empirically to what extent the HAq-II has
improved over the HAq-I. The sample included 
60 self-referred outpatients assigned to a Brief Psy-
chodynamic Investigation (BPI), a manual-based
investigation procedure in four sessions guided 
by psychodynamic principles. We looked at the
correlation between the two HAq (I and II) and 
the Working Alliance Inventory (WAI), patient
pretreatment characteristics (SCL-90, HDRS,
HAMA, IIP) and outcome (SCL-90, SAS and
patient satisfaction).
Results showed that the French version of the
HAq-II has good psychometric properties. Esti-
mates of internal consistency and test-retest relia-
bility were fairly similar to the original English
version. Indication of its validity included high
correlation with other alliance measures and inde-
pendence from patient pretreatment characteris-
tics. Surprisingly, HAq-II score predicted patient’s
satisfaction with the treatment but not sympto-
matic improvement. Taken together, these first
results are promising and indicate that the trans-
lated version of the HAq-II is a valid instrument
for measuring the helping alliance.
Concerning the comparison between the two
versions of the HAq, HAq-II has proved to be an
improvement compared to the original HAq-I
scale: it better relates to the alliance construct and
it is less influenced by the symptoms of the patient.
Considering also its better construct validity
(Luborsky et al., 1996), we definitely recommend
the use of the revised HAq-II instead of the initial
version of the scale.
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Scientific interest in the concept of alliance has
been maintained and stimulated by repeated
findings that a strong alliance is associated with
better final outcome. Two meta-analyses found an
overall relation of alliance-outcome correlation of
r = 0.26 (Horvath and Symonds, 1991) and r = 0.22
(Martin, Garske and Davis, 2000).
However, there is little agreement on the best
way to measure the therapeutic alliance. Among
the instruments available, the (1) Helping Alliance
questionnaire (HAq-I) developed by Lester Lu-
borsky (see Alexander and Luborsky, 1986) is 
one of the most widely used, together with (2) 
the Working Alliance Inventory (WAI) (Horvath
and Greenberg, 1986), (3) the California Psycho-
therapy Alliance Scale (CALPAS) (Marmar,Weiss
and Gaston, 1989), and (4) the Vanderbilt Thera-
peutic Alliance Scale (VTAS) (Hartley and Strupp,
1983). Even if these instruments were based on dif-
ferent theoretical grounds, a comparison between
them showed that they all had good psychometric
properties (Tichenor and Hill, 1989), they tap into
the same core general aspects of the construct, that
is, the confident collaboration and bond between
patient and therapist (Hatcher and Barends, 1996),
and they are minimally different with respect to
predictive validity (Fenton et al., 2001).
Each scale also has unique features. For exam-
ple Barber et al. (1999) showed that despite rela-
tively high correlation between HAq-II and
CALPAS, the HAq-II was more sensitive in pre-
dicting outcome, whereas the CALPAS was more
sensitive in predicting retention in treatment.
According to the circumstances, the overlap be-
tween the different instruments varied from 12 to
76% (M = 35%). It is then problematic for investi-
gators to choose among the existing instruments 
on the basis of considerations other than ease of
administration, continuity with previous research
or availability.
Revising the Helping Alliance questionnaire
The original HAq appeared to be the most pre-
dictive of outcomes, with a mean correlation of 
r = 0.29 in 24 studies (Martin, Garske and Davis,
2000). However, this result is problematic, given
that 5 of the 11 items were explicitly related to
symptom improvement (i.e. “I have been feeling
better recently” or “I believe that the treatment is
helping me”).This multidimensionality of the scale
was confirmed by Bassler (2002) who found two
factors on a sample of 231 inpatients: (1) the pa-
tient’s satisfaction with therapeutic success, which
includes the 5 items related to symptom improve-
ment, and (2) the patient’s satisfaction with the
therapeutic relationship, which includes the other
6 items more closely related to Bordin’s concept of
mutual agreement on tasks (i.e. “I feel I am work-
ing together with the therapist in a joint effort”)
and goals (i.e.“I feel the therapist wants to achieve
my goals”). For Hatcher and Barends (1996) the
HAq’s questions were too general to discriminate
aspects of alliance effectively and the emphasis of
the scale on help received made it actually a mea-
sure of outcome.
In order to address these issues and to better
measure the core construct of mutual collabora-
tion, a revised version (HAq-II) was developed
(Luborsky et al., 1996). Six items were deleted and
14 new items expected to better reflect the various
aspects of the collaborative effort between patient
and therapist were added (“the therapist and I have
meaningful exchanges” or “a good relationship has
formed with my therapist” for example).
As a result, HAq-II was viewed as an improve-
ment over HAq-I. A first validation study on a
sample of 246 cocaine-dependent outpatients (Lu-
borsky et al., 1996) showed – as expected – a good
convergent validity between the new scale and the
CALPAS and no association with pretreatment
psychiatric severity. However, the two versions 
of the scale have not yet been administered con-
currently. This prevents us from concluding that
HAq-II is more valid than HAq-I and it questions
whether the instrument is an improvement of the
first version or an other instrument with its own
unique features.
This article is dedicated to a comparison be-
tween the original and the revised version of HAq.
We will look at (1) the relation between the two
instruments and with other alliance measures, (2)
the relation with pretreatment symptoms, and (3)
the relation with outcome. As an improved instru-
ment, HAq-II should show more correlation with
other alliance instruments, less correlation with
pretreatment symptoms and at least as much cor-
relation with outcome as HAq-I.
Method
Sample
The sample included self-referred outpatients 
(N = 60) from the Adult Psychiatry outpatient unit
of the University of Lausanne.All were assigned to
a Brief Psychodynamic Investigation (BPI) carried
out over four sessions. The general criteria for
participation in the study included an age category
of 17 to 60 years and a minimum of one diagnosis
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related to anxiety, depression or personality dis-
orders. Exclusion criteria included organic or
delirium disorders, substantial alcohol or drug
dependence, psychotic or bipolar disorders, mental
retardation and antisocial personality disorder.
The patients were comprised of 23 men (38.4%)
and 37 women (61.6%) with a mean age of 29.43
(SD = 8.9). Most of them were seeking therapeutic
help for mood (63.3%) or anxiety disorders
(36.7%), and occasionally for eating (5.0%) or
sexual (5.0%) disorders. Some comorbidity was
detected as the mean number of DSM-IV Axis I
diagnoses were two disorders. Finally, 38% pre-
sented a Cluster C personality disorder on Axis II.
The treatments were conducted by ten thera-
pists (3 of them women) affiliated with the Adult
Psychiatric Department of the University of Lau-
sanne. All therapists had much experience in the
practice of psychodynamic therapy with a mean of
19 years of experience (ranging from 8 to 38 years)
and were shown to be highly competent in BPI
(Tadic et al., 2003).
Measures
Helping Alliance questionnaire-I (HAq-I). It is a
widely used 11-item questionnaire that measures
the strength of the patient-therapist therapeutic
alliance (Alexander and Luborsky, 1986; Gérin,
Dazord and Sali, 1991, for the French version).
Each item is rated on a six-point Likert scale (from
–3 = I strongly feel it is not true to +3 = I strongly
feel it is true). In a meta-analytic review, Martin,
Garske and Davis (2000) showed that HAq-I has
adequate psychometric properties (overall relia-
bility of 0.74) and was particularly good in pre-
dicting outcomes (average r = 0.29).Validated on a
sample of 34 patients during long-term dynamic
psychotherapy, the French version of the scale
showed good internal consistency (α = 0.88), and
high correlations with the WAI at session 5 and 
10 (r = 0.79 and 0.80 respectively) and with the
CALPAS (r = 0.79 and 0.82 respectively) (Bache-
lor, 1991).
Helping Alliance questionnaire-II (HAq-II). It
is a new 19-item questionnaire where 6 out of the
11 items from the original HAq-I were removed
and 14 items added. Each item is rated on a six-
point Likert scale (1 = I strongly feel it is not true;
6 = I strongly feel it is true).
In a study of the psychometric properties of 
the scale on a sample of 246 patients diagnosed 
with cocaine dependence, Luborsky et al. (1996)
reported an excellent internal consistency coef-
ficient (Cronbach’s alphas ranged from 0.90 to
0.93) and test-retest reliability (r = 0.78 for patient
version).The scale demonstrated good convergent
validity with the CALPAS (correlations ranged
between 0.59 and 0.71, depending on the session
assessed) and was not associated with pretreatment
psychiatric severity or level of depression.
The French translation was done by two re- 
searchers working independently. A consensual
third version was then made which was translated
back and compared with the original English
version. Internal consistency (Cronbach’s alphas
ranged from 0.85 to 0.91) was fairly comparable to
the original English version.
Outcome. Measures include symptom distress
(Symptom Check-List), depression (Hamilton
Depression Rating Scale) and anxiety (Hamilton
Anxiety), Social adjustment (Social Adjustment
Scale), interpersonal Problems (Inventory of Inter-
personal Problems), and patient satisfaction (Pa-
tent satisfaction Questionnaire developed by de
Roten, 1999). This last instrument assesses the
patient’s level of satisfaction with the treatment.
It includes the following 5 questions: (1) Do you
consider these sessions to have been helpful?; (2)
Do you consider that you have reached the goals
you had set?; (3) Do you feel satisfied with the
sessions?; (4) Do you feel that you have changed
thanks to these sessions?; and (5) Do you feel that
these sessions have improved your symptoms?
Each question is to be answered using a seven-
point Likert-type scale.
Treatment
The majority of patients who come to our out-
patients clinic for consultation begin treatment
with a Brief Psychodynamic Investigation (BPI)
over four sessions (Gilliéron, 1997). The BPI is a
formalised, manual-based investigation procedure
guided by psychodynamic principles.
Furthering the development of the therapeutic
alliance is one of the major aims of the BPI.As such
BPI is a particularly pertinent context for studying
early alliance. We showed (de Roten et al., 2004)
that alliance changed significantly during BPI for
about 80% of our patients.
Data analysis
Alliance in all 4 sessions of the BPI was examined.
First, the normal distribution of the data (HAq-I
and HAq-II) was tested using Kolmogoroff-
Smirnoff test. Pearsons product-moment correla-
tion was used to examine the relation between
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HAq-II and the other measures (alliance scales 
and symptomatic distress). Partial correlations
controlling for pretreatment level were used to
examine the relation between HAq-II and the out-
come measures.
Results
HAq-II scores changed during the treatment, with
F (3.57) = 5.53, p 0.01 (see table 1). Compared to
other studies, (i.e., Barber et al., 1999), alliance
scores were not very high at the end of the first
session (114 for HAq-II) and increased only
moderately over the course of the four sessions.
Relation between alliance measures
Table 2 shows the correlations between the patient
version of HAq-II and the patient version of 
HAq-I for each of the four sessions and the ob-
server version of the WAI for session 2 and 4. Two
independent coders rated the WAI (median Intra-
Class Coefficient of 0.76).
The two versions of the HAq were highly cor-
related (overall r = 0.75, p 0.001).The WAI scales
were also correlated with the HAq-II, indicating 
a fair amount of the variance shared by the two
instruments, whereas the correlations with HAq-I
were lower (ranging from r = 0.17 to r = 0.34).
Influence of pretreatment patient characteristics
There was no correlation found between pre-
treatment measures of patient problems (SCL-90,
HDRS, HAMA, IIP) and either version of the
HAq. The only exception concerns the Social
Adjustment Scale (SAS) which was correlated with
the HAq-I at each session (ranging from r = –0.22
to r = –0.35).
Confirming results from the validation study of
the original English version (Luborsky et al.,1996),
no correlation was found between HAq (I and II)
and socio-demographic variables such as age, sex,
marital status and employment.
Prediction of outcome
Table 3 shows the correlations between HAq (I and
II) and outcomes.There is a change between intake
and end of the treatment for Global Symptom 
Index (GSI) (t [59] = 4.46, p 0.001), and for 
SAS (t [59] = 2.95, p 0.05). We see in table 3 that
HAq-I is related to GSI and SAS,but only for those
sessions where outcomes are measured. As ex-
pected, it is the “satisfaction with the treatment”
factor that is correlated with GSI (partial r = 0.34,
p 0.01) and with SAS (partial r = 0.36, p 0.01),
and not the “satisfaction with the relationship” fac-
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Descriptives of HAq-II score at each session (N = 60).
HAq-II M SD min max
session 1 84.12 11.4 61 114
session 2 87.47 12.3 59 111
session 3 89.73 13.2 52 111
session 4 90.54 14.4 52 113
HAq-II = revised Helping Alliance questionnaire II, 
patient version.
Table 1
Correlations between HAq-II and other alliances’ scales (N = 60).
scale HAq-II, patient version
S 1 S 2 S 3 S 4
HAq-I, patient 
total 0.75 0.81 0.76 0.81
F1. relationship 0.82 0.87 0.85 0.88
F2. success 0.48 0.56 0.57 0.58
WAI, observer
bond – 0.42 – 0.39
tasks – 0.51 – 0.43
goals – 0.35a – 0.41
total – 0.45 – 0.41
HAq-I = Helping Alliance questionnaire I; HAq-II = revised Helping Alliance questionnaire II; WAI = Working Alliance Inventory; 
S 1, S 2, S 3, S 4 = Session 1, 2, 3, 4; F1. = Factor 1 “satisfaction with the relationship”; F2. = Factor 2 “satisfaction with
the therapeutic success”; all correlations p <0.001, except a p <0.01.
Table 2
tor. No correlations with GSI or SAS were found
with HAq-II, even when considering these two
factors.
Discussion
In this report we present some psychometric data
on the French version of the HAq-II, a revised
version of the Helping Alliance questionnaire
which is one of the mostly used instruments for
measuring therapeutic alliance. Estimates of in-
ternal consistency and test-retest reliability were
fairly similar to the original English version. Indi-
cation of its validity included high correlation with
other alliance measures and independence from
patient pretreatment characteristics. Surprisingly,
HAq-II score predicted patient’s satisfaction with
the treatment but not symptomatic improvement.
Taken together, these first results are promising
and indicate that the translated version of the
HAq-II is a valid instrument for measuring the
helping alliance.
A further question – not documented yet – was
investigated: To what extent was the HAq-II im-
proved over the HAq-I? HAq-I has the advantage
of being very short and Luborsky (2000) has shown
that its validity is at least as good as the other
instruments used in the field. The construction of
the second version was guided by two main goals:
(1) to better incorporate the various aspects of the
alliance as described, for example,by Bordin (1979)
and which are related to the collaborative effort of
patient and therapist, and (2) to reduce the incli-
nation of the scale toward measuring early symp-
tomatic improvement and thus confusing these two
dimensions.
Measuring the alliance construct
Regarding Bordin’s components of the alliance,
HAq-II offers a better convergence with the WAI
scale and subscales. Correlations ranging from 
0.35 to 0.51 were twice as high when compared with
HAq-I; they were significant as compared with all
dimensions of the WAI and for the two coded
sessions. Compared to the correlations usually
reported between patient and observer-rated in-
struments (Fenton et al., 2001), these are relatively
high, indicating a fair amount of shared common
variance.
Influence of symptomatic distress and early 
improvement
Both instruments showed to be independent from
pretreatment symptomatology except social ad-
justment. As expected, HAq-I was correlated with
SAS at each of the four sessions, whereas there
were no correlations with HAq-II. This result may
be explained when considering our sample. It was
comprised of patients who did not show the same
symptoms (mean GSI = 0.89, SD = 0.50) and who
sought help mostly when facing a crisis with their
environment (SAS at intake, M = 2.07, SD = 0.37).
It was also observed that correlation rises with each
session. Given that the alliance also tends to in-
crease with each session and that problems of social
adjustment are reduced during treatment (SAS
after the four sessions,M = 1.93,SD = 0.48),we may
conclude that the improvements following the
crises also have an influence on the alliance mea-
sure concerning the HAq-I but not the HAq-II.
This type of improvement, inherent in the 
HAq-I, is found in the outcome measures. The
HAq-I conducted during the fourth session is
correlated with the GSI and the SAS after the
fourth session. Yet, only the items concerning
symptoms (the “satisfaction with the treatment”
factor) predicted the symptomatic improvement,
which is rather tautological.That is why these items
were removed in the revised version. There is,
however, no correlation between HAq-II and the
outcome measures.
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Correlations between alliance and outcome (N = 60). 
HAq-I HAq-II
S 1 S 2 S 3 S 4 S 1 S 2 S 3 S 4
Symptom Check List (SCL-90r)
GSIa 0.15 0.14 –0.10 –0.28* 0.24 0.10 0.06 –0.04
Social Adjustment Scale (SAS-SR)
SASa 0.04 0.03 –0.13 –0.38*** 0.13 0.08 0.10 –0.16
Patient Satisfaction Questionnaire (PSQ)
PSQ 0.33** 0.52*** 0.62*** 0.80*** 0.17 0.47*** 0.59*** 0.64***
a Partial correlation controlling for pretreatment level.
* p <0.05; ** p <0.01; *** p <0.001.
Table 3
Finally, when the patient’s satisfaction is con-
sidered, both versions of the HAq showed signi-
ficant correlations. As suggested by Hatcher and
Barends (1996), helpfulness is an important aspect
of patients’ perception of the alliance.However, the
comparison between the two versions of the HAq
showed that patients are to some degree able to
distinguish between helpfulness as a process which
they expect will lead to a favourable good outcome
(alliance) and helpfulness as related to actual
changes in their problems (improvement).
Conclusion
HAq-II has proved to be an improvement com-
pared to the original HAq-I scale: (1) it better
relates to the alliance construct and (2) it is less
influenced by the symptoms of the patient. Con-
sidering also its better construct validity (Luborsky
et al., 1996), we definitely recommend the use of 
the revised HAq-II instead of the initial version 
of the scale.
Further research is needed to study common
and specific factors in HAq-II when compared to
other alliance instruments. For example, Barber 
et al. (1996) showed that CALPAS and HAq-II,
despite a relatively high correlation between the
two, have different abilities in predicting retention
and outcome for patients being treated for cocaine
dependence.
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